Pharmacology · Glossary
Adverse event
Also written: AE
Definition
An adverse event is anything harmful recorded during a trial, whether or not the drug caused it — which is why placebo groups report them too.
The adverse event meaning is simple: an adverse event is anything harmful recorded during a trial, whether or not the drug caused it. Researchers log what happened first and judge causation separately. That is why placebo groups report adverse events too, and why an adverse-event table is not automatically a list of side effects.
What is an adverse event vs side effect?
An adverse event records timing; a side effect implies that the treatment caused an effect. FDA’s clinical-trial definition covers any harmful medical occurrence associated with drug use, whether or not investigators consider it drug-related. A headache, abnormal lab result, injury, or worsening illness can therefore enter the AE log before anyone knows why it happened.
The clean version of adverse event vs side effect is: “after treatment” is not the same claim as “because of treatment.” Our peptide side-effects hub focuses on risks with evidence of a relationship, while the AE column preserves the wider safety record.
Why do placebo groups report adverse events?
Placebo groups report adverse events because people still get headaches, infections, injuries, abnormal tests, and worsening symptoms during a study. In one cagrilintide phase 1b trial, 97% of participants receiving cagrilintide plus semaglutide and 96% receiving placebo plus semaglutide reported at least one AE. The raw percentages look alarming; the comparison changes the reading.
When reading an RCT, compare the treatment and control arms, then check the event type, severity, timing, and investigator’s causality assessment. A long AE table can reflect careful surveillance rather than a dangerous drug. The guide to reading peptide evidence applies the same discipline to benefit claims.
What do serious and treatment-emergent adverse event mean?
A serious adverse event meets an outcome-based threshold such as death, immediate danger to life, hospitalization, lasting disability, or a birth defect. “Serious” is not a synonym for “severe”: a severe headache can be non-serious, while a mild event requiring hospitalization can be serious under the reporting rules.
A treatment emergent adverse event is new after treatment starts or worsens from the pretreatment baseline, according to the NCBI definition. “Treatment emergent” still describes timing, not proof of cause. The useful question is never just “How many AEs?” It is “Which events increased versus the control, how serious were they, and did the evidence support causation?”